### Comment:
It'll be halted tomorrow due to there being an FDA advisory committee on how broad of a label their drug Vascepa should receive. The actual drug approval should be by or before 12/28 but the adcom results are basically it getting approved or not. If it gets a broad label recommendation then it'll be in line to compete with drugs like Lipitor and be a potential candidate for a buyout. 
  
 Edit: but see above, I'm retard so take with grain of salt

### REPLY:
Can't take it with a grain of salt. Already balls deep.... 
  
 Honestly,  I wanted to already be on board. Just needed a catalyst to pull the trigger.

### END.